Potential assessment of non-invasive portal pressure measurement by the microbubble contrast agents

Potential assessment of non-invasive portal pressure measurement by the microbubble contrast agents - Non-invasive assessment of portal pressure by the microbubble contrast agents

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015390

Enrollment

Registered

2014-10-10

Start date

2008-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Microbubble contrast agents

Sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who were planned to receive percutaneous transhepatic portal venography or hepatic venograghy 2. Having received adequate explanation of the contents of the trial and given their written consent

Exclusion criteria

Exclusion criteria: 1. Egg allergy 2. Severe lung and/or heart disease 3. Determined to be ineligible by the physician in charge for any other reason

Design outcomes

Primary

Measure	Time frame
To compare portal vein pressure with the quantitative contrast parameters of using contrast-enhanced ultrasonography	—

Countries

Japan

Contacts

Public ContactHitoshi Maruyama

Chiba University Graduate School of Medicine Department of Gastroenterology and Nephrology

maru-cib@umin.ac.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026